| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |